Emend Merck - Treatment for Chemotherapy-Induced Nausea and Vomiting (CINV)

Emend is a P/neurokinin 1 (NK1) receptor antagonist used in combination with other antiemetic agents to prevent and control acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy.

Posted: March 2003

View comments

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here